HRTX Heron Therapeutics Inc

Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.

$2.70  -0.09 (-3.23%)
As of 07/01/2022 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/27/1987
Outstanding shares:  102,479,577
Average volume:  3,051,244
Market cap:   $285,918,020
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ0XLZ3
Valuation   (See tab for details)
PE ratio:   -1.20
PB ratio:   11.57
PS ratio:   3.16
Return on equity:   -968.18%
Net income %:   -255.97%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy